当前位置: X-MOL 学术Int. J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Leptomeningeal metastases arising from gynecological cancers.
International Journal of Clinical Oncology ( IF 2.4 ) Pub Date : 2019-10-04 , DOI: 10.1007/s10147-019-01556-1
Hiroko Yano 1 , Shoji Nagao 1 , Satoshi Yamaguchi 1
Affiliation  

BACKGROUND Most cases of leptomeningeal metastasis (LM) arise from solid tumors, such as breast cancer, lung cancer, or malignant melanoma. LM arising from gynecological cancers are extremely rare. Longer survival owing to recent advances in chemotherapy and other treatments has contributed to the increased frequency of gynecological cancers metastasizing to the central nervous system (CNS). Detailed information regarding LM is scarce; therefore, we conducted a study concerning LM arising from primary gynecological cancers. METHODS Among 24 patients with CNS metastases from gynecological cancer treated at our hospital between January 2011 and August 2018, those who were eventually diagnosed with LM were included in this retrospective study. RESULTS Among 24 patients with CNS metastases, five patients (20.8%) were diagnosed with LM. The primary cancer was endometrial in two, cervical in one, and peritoneal in two patients. Of these five patients, three developed LM as a complication 1-11 months after the treatment of brain metastases; one patient had multiple brain metastases diagnosed at the same time as LM, and one had LM alone, without accompanying brain metastases. The median survival after the diagnosis of LM was 23 (12-69) days, while the median survival of 24 patients after the initial diagnosis of CNS metastases was 106 (13-959) days. CONCLUSION Although LM arising from gynecological cancers is considered rare, identification of LM may be important to predict prognosis and develop new therapeutic strategies.

中文翻译:

妇科癌症引起的软脑膜转移。

背景技术软脑膜转移瘤(LM)的大多数病例都来自实体瘤,例如乳腺癌,肺癌或恶性黑色素瘤。由妇科癌症引起的LM极为罕见。由于化学疗法和其他疗法的最新进展,更长的生存期导致了妇科癌症转移到中枢神经系统(CNS)的频率增加。缺乏有关LM的详细信息;因此,我们进行了一项有关原发性妇科癌症引起的LM的研究。方法回顾性研究纳入2011年1月至2018年8月间在我院接受治疗的24例因妇科癌症引起的CNS转移的患者。结果24例中枢神经系统转移患者中,有5例(20.8%)被诊断为LM。原发癌是子宫内膜癌两个,宫颈癌一个,腹膜癌两个。在这五名患者中,三名在转移脑瘤后1-11个月发展为LM。一名患者与LM同时被诊断出有多处脑转移,而一名患者只有LM,没有伴随的脑转移。LM诊断后的中位生存期为23(12-69)天,而最初诊断为CNS转移后的24名患者中位生存期为106(13-959)天。结论尽管妇产科癌症引起的LM被认为是罕见的,但LM的鉴定对于预测预后和开发新的治疗策略可能很重要。在脑转移瘤治疗后的1-11个月内,有3例发展为LM。一名患者与LM同时被诊断出有多处脑转移,而一名患者只有LM,没有伴随的脑转移。LM诊断后的中位生存期为23(12-69)天,而最初诊断为CNS转移后的24名患者中位生存期为106(13-959)天。结论尽管妇产科癌症引起的LM被认为是罕见的,但LM的鉴定对于预测预后和开发新的治疗策略可能很重要。在脑转移瘤治疗后的1-11个月内,有3例发展为LM。一名患者与LM同时被诊断出多处脑转移,而一名患者仅患有LM,而没有伴随的脑转移。LM诊断后的中位生存期为23(12-69)天,而最初诊断为CNS转移后的24名患者中位生存期为106(13-959)天。结论尽管妇产科癌症引起的LM被认为是罕见的,但LM的鉴定对于预测预后和开发新的治疗策略可能很重要。最初诊断为CNS转移后,24例患者的中位生存期为106(13-959)天。结论尽管妇产科癌症引起的LM被认为是罕见的,但LM的鉴定对于预测预后和开发新的治疗策略可能很重要。最初诊断为CNS转移后,24例患者的中位生存期为106(13-959)天。结论尽管妇产科癌症引起的LM被认为是罕见的,但LM的鉴定对于预测预后和开发新的治疗策略可能很重要。
更新日期:2020-01-30
down
wechat
bug